- Home
- PDCO vs CERT Comparison
PDCO vs CERT Comparison
Compare PDCO & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDCO
- CERT
- Stock Information
- Founded
- PDCO 1877
- CERT 2008
- Country
- PDCO United States
- CERT United States
- Employees
- PDCO N/A
- CERT N/A
- Industry
- PDCO Medical Specialities
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- PDCO Health Care
- CERT Technology
- Exchange
- PDCO Nasdaq
- CERT Nasdaq
- Market Cap
- PDCO 2.7B
- CERT 2.3B
- IPO Year
- PDCO 1992
- CERT 2020
- Fundamental
- Price
- PDCO $31.07
- CERT $13.17
- Analyst Decision
- PDCO Hold
- CERT Buy
- Analyst Count
- PDCO 10
- CERT 7
- Target Price
- PDCO $27.07
- CERT $15.92
- AVG Volume (30 Days)
- PDCO 852.1K
- CERT 1.4M
- Earning Date
- PDCO 03-03-2025
- CERT 02-26-2025
- Dividend Yield
- PDCO 2.51%
- CERT N/A
- EPS Growth
- PDCO N/A
- CERT N/A
- EPS
- PDCO 1.72
- CERT N/A
- Revenue
- PDCO $6,554,872,000.00
- CERT $372,797,000.00
- Revenue This Year
- PDCO $2.68
- CERT $10.48
- Revenue Next Year
- PDCO $2.86
- CERT $9.94
- P/E Ratio
- PDCO $18.02
- CERT N/A
- Revenue Growth
- PDCO 0.05
- CERT 5.62
- 52 Week Low
- PDCO $19.45
- CERT $9.41
- 52 Week High
- PDCO $31.79
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- PDCO 77.13
- CERT 48.29
- Support Level
- PDCO $31.01
- CERT $13.54
- Resistance Level
- PDCO $31.10
- CERT $15.69
- Average True Range (ATR)
- PDCO 0.04
- CERT 0.70
- MACD
- PDCO -0.10
- CERT -0.16
- Stochastic Oscillator
- PDCO 87.50
- CERT 2.70
About PDCO Patterson Companies Inc.
Patterson Companies Inc is a dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives its revenue from the United States, the United Kingdom, and Canada. The firm derives almost all of its revenue from the United States.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.